Global Point of Care Glucose Testing Market projected to grow to approximately USD 5,455.3 million by 2033, positive.
From GlobeNewswire: 2024-11-27 01:30:00
The global Point-of-Care Glucose Testing Market is projected to grow from USD 3,670.9 million in 2024 to approximately USD 5,455.3 million by 2033, with a CAGR of 4.5%. Factors driving this growth include rising diabetes prevalence, technological advancements, self-monitoring adoption, awareness programs, aging population, homecare settings, digital health integration, and preventive healthcare focus.
In 2024, DexCom launched the Dexcom ONE+ real-time continuous glucose monitoring system in Spain, Belgium, and Poland, with plans for expansion. Avricore Health and Ascensia Diabetes Care partnered to integrate blood glucose monitoring into point-of-care testing. EKF Diagnostics introduced the STAT-Site WB handheld analyzer globally for rapid ketone and glucose measurements from whole blood. The Point-of-Care Glucose Testing Market is projected to reach USD 5,455.3 million by 2033, with a 4.5% CAGR growth rate. The COVID-19 pandemic impacted the industry by disrupting healthcare services, shifting patient behavior, increasing telehealth adoption, promoting homecare solutions, and emphasizing chronic disease management.
During the pandemic, healthcare systems faced disruptions, leading to a temporary decline in demand for glucose testing. Patient behavior changed, reducing utilization of testing devices. Telehealth and remote monitoring solutions saw increased adoption, driving demand. Homecare solutions flourished, and routine healthcare services gradually resumed with a focus on chronic disease management. The COVID-19 pandemic has impacted the Point-of-Care Glucose Testing Market, presenting challenges and opportunities. Key questions addressed include market size, growth rate, top companies, market segments, and fastest-growing regions. The report offers market share, forecasts, dynamics, segmentation, and competitive landscape. Regional analysis shows trends in North America, Europe, Asia-Pacific, and LAMEA, highlighting factors driving market growth in each region. Prominent players in the market include Abbott Laboratories, Hoffmann-La Roche Ltd., Ascensia Diabetes Care Holdings AG, Dexcom Inc., Medtronic plc, and LifeScan Inc. For more information and customized reports, visit the link provided. The global Point-of-Care Glucose Testing Market includes key players such as Johnson & Johnson Company, Becton Dickinson and Company, Acon Laboratories Inc., Nova Biomedical Corporation, ARKRAY Inc., Trividia Health Inc., PTS Diagnostics, Nipro Diagnostics Inc., Ypsomed Holding AG, Sanofi S.A., and others. For a free sample report, visit the link provided.
This market report offers comprehensive coverage with a maximum number of market tables and figures. The subscription-based option is available with a best price guarantee. Customers can enjoy free customization, post-sale service assistance, and a 25% discount on their next purchase. Service guarantees and personalized market briefs by the author are also provided. 1. The stock market surged today with the S&P 500 gaining 2.5% and the Dow Jones Industrial Average rising 3%. This comes after positive economic data showing a decrease in unemployment rates and an increase in consumer spending.
2. A new study has shown that 80% of Americans are in favor of stricter gun control laws, with 65% supporting a ban on assault weapons. The survey also revealed that 70% believe that gun violence is a major problem in the country.
3. The FDA has approved a new drug for the treatment of Alzheimer’s disease, the first of its kind in nearly two decades. The medication, Aduhelm, has shown promising results in slowing down the progression of the disease in clinical trials.
4. The United Nations has declared that the world is facing a “code red for humanity” due to the impacts of climate change. The latest report from the Intergovernmental Panel on Climate Change warns of irreversible damage to the planet if urgent action is not taken to reduce greenhouse gas emissions.
5. In entertainment news, actor Tom Cruise has announced that he will be filming a movie in space with the help of SpaceX and NASA. The project, which is set to be the first narrative feature film shot in space, aims to push the boundaries of filmmaking and space exploration. 1. Apple announces record-breaking quarterly revenue of $111.4 billion, driven by strong iPhone sales and growth in services like Apple Music and Apple TV+.
2. Scientists discover a new species of dinosaur in Argentina, named Llukalkan aliocranianus, with a unique skull structure and sharp teeth.
3. The CDC reports that the number of COVID-19 cases in the United States has surpassed 25 million, with over 420,000 deaths since the start of the pandemic.
4. Tesla CEO Elon Musk becomes the world’s richest person, surpassing Amazon’s Jeff Bezos, with a net worth of over $185 billion.
5. The WHO warns of a global shortage of COVID-19 vaccines, with developing countries struggling to secure enough doses for their populations.
6. Facebook bans political ads in the United States following the Capitol riots, in an effort to prevent misinformation and promote a peaceful transition of power.
Read more at GlobeNewswire: [Latest] Global Point of Care Glucose Testing Market